As per the research report, the Asia pacific Microbiome sequencing services market size is valued at USD 153.53 Million in 2022. It is expected to grow at a CAGR of 24.92% to reach USD 467.03 Million by 2027 during the forecast period 2022 to 2027.
Human microbiome research aims to understand the function of bacteria in health and disease. Microbiome sequencing investigates microbial groups found in and on the human body. Previously, analyzing samples from human skin, stool, or blood required time-consuming and labor-intensive microbiological methods such as cultivating and isolating individual organisms, then phenotypic or genotypic analysis.
However, with the emergence of next-generation sequencing (NGS), a wave of high-profile collaborative initiatives have published a lot of data on the human microbiome using NGS as a critical technology.
The growing use of microbiomes in genomics, proteomics, metabolomics, and mechanical advancements in cutting-edge sequencing are driving the market growth.
On the other hand, the demand for microbiome sequencing services is fueled by rising healthcare spending in metropolitan areas and expanding government support through investments. In addition, the growing importance of early diagnosis, as some diseases can be completely cured if detected early, is driving market demand.
The market is being fueled by the growing size of the pharmaceutical industry and increased awareness of the benefits of microbiome sequencing for cancer treatment. The rise in chronic disease occurrences is having a substantial impact on market demand. The market is being fueled by the growing size of the pharmaceutical industry and increased awareness of the benefits of microbiome sequencing for cancer treatment. The rise in chronic disease occurrences is having a substantial impact on market demand.
However, the government's stringent laws and restrictions, the cost of installing and maintaining the equipment are a little high; these factors are also predicted to hamper the market growth of the global microbiome sequencing services. In addition, the market expansion might be hindered by a lack of innovation combined with extensive analysis. Furthermore, the market growth rate is being slowed by fewer technicians, physicians, and scientists. Finally, the high cost of laboratory equipment also hinders the market for microbiome sequencing services.
This research report on the APAC Microbiome Sequencing Services Market has been segmented and sub-segmented into the following categories:
By Research Type:
By Laboratory Type:
By End User:
The APAC microbiome sequencing services market is anticipated to account for a significant share during the forecast period. Due to breakthrough ways of detecting the condition, Asia Pacific is ranked second in the industry with the most considerable market proportion. Asia Pacific is the fastest region in growth, with a substantial CAGR in the years ahead. The continual advancement of sequencing technology and new procedures for identifying diseases are credited with the region's growth.
The China microbiome sequencing services market held the most significant global market share. The market growth is linked to the advancement of sequencing technology and the introduction of novel processes for diagnosing disorders. Also, the large patient pool of chronic diseases and government healthcare reform measures are predicted to develop steadily during the forecast period.
The India microbiome sequencing services market and Japan microbiome sequencing services market are projected to showcase a considerable share globally in the coming years. On-going technological advancements in the healthcare sector, improving the healthcare sector, and supportive government policies drive market growth.
The Top Companies in the APAC Microbiome sequencing services market profiled in the report are Metabiomics Corp., Microbiome Therapeutics LLC, Microbiome Insights Inc., Rancho Biosciences, Zymo Research Corp., Molzym GmbH & Co., Ubiome Inc., Diversigen Inc., Merieux Nutrisciences Corporation, and Molecular Research LP.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 sequencing by synthesis
5.1.3 sequencing by ligation
5.1.5 sanger sequencing
5.1.6 Other technologies
5.1.7 Y-o-Y Growth Analysis, By Technology
5.1.8 Market Attractiveness Analysis, By Technology
5.1.9 Market Share Analysis, By Technology
5.2.2 shotgun sequencing
5.2.3 targeted gene sequencing
5.2.4 RNA sequencing
5.2.5 whole genome sequencing
5.2.6 Other applications
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
5.3 Research type
5.3.2 Internal research
5.3.3 Outsourced researchDrug
5.3.4 Y-o-Y Growth Analysis, By research type
5.3.5 Market Attractiveness Analysis, By research type
5.3.6 Market Share Analysis, By research type
5.4 Laboratory type
5.4.2 Wet lab
5.4.3 Dry lab
5.4.4 Y-o-Y Growth Analysis, By Laboratory type
5.4.5 Market Attractiveness Analysis, By Laboratory type
5.4.6 Market Share Analysis, By Laboratory type
5.5 End user
5.5.4 Y-o-Y Growth Analysis, By End user
5.5.5 Market Attractiveness Analysis, By End user
5.5.6 Market Share Analysis, By End user
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Technology
184.108.40.206 By Application
220.127.116.11 By Research type
18.104.22.168 By laboratory type
22.214.171.124 By End user
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Technology
184.108.40.206 By Application
220.127.116.11 By Research type
18.104.22.168 By laboratory type
22.214.171.124 By End user
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Technology
184.108.40.206 By Application
220.127.116.11 By Research type
18.104.22.168 By laboratory type
22.214.171.124 By End user
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Metabiomics Corp
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Microbiome Therapeutics LLC
8.3 Microbiome Insights Inc.
8.4 Rancho Biosciences
8.5 Zymo Research Corp
8.6 Molzym GmbH & Co.
8.7 Celgene Corporation
8.8 Ubiome Inc.
8.9 Diversigen Inc.
8.10 Merieux Nutrisciences Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.